Monitor the following: Public Law 119-75, Consolidated Appropriations Act, 2026, Division B - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Diagnostic Lab Testing related issues President's Budget FY2027
2026 · 2nd Quarter (Apr 1 - June 30)
ARUP LABORATORIES, INC.
Filed by VAN SCOYOC ASSOCIATES.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 17, 2026
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- VAN SCOYOC ASSOCIATES
- Client
- ARUP LABORATORIES, INC.
- Filing UUID
- 254bfe4c-79ff-44b2-ba7e-edf581d0c5ba
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
FDA regulation, Laboratory Testing related issues H.R.8890, Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Monitor the following: Possible Health policy package Health workforce visa related issues H.R.3152/S.1546, Patent Eligibility Restoration Act of 2025, Laboratory technology related issues Possible Reconciliation, FY2026 and FY2027, Health related provisions Prescription drug costs, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives
Literal federal measure citations: H.R.8890, H.R.5269, S.2761, H.R.3152, S.1546
FDA regulation, Laboratory Testing related issues H.R.8890, Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Monitor the following: Possible Health policy package Health workforce visa related issues H.R.3152/S.1546, Patent Eligibility Restoration Act of 2025, Laboratory technology related issues Possible Reconciliation, FY2026 and FY2027, Health related provisions Prescription drug costs, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives
Literal federal measure citations: H.R.8890, H.R.5269, S.2761, H.R.3152, S.1546
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.